Pregled bibliografske jedinice broj: 26277
Platelet aggregation in type 1diabetes withouth microvascular disease during continuous subcutaneous insulin infusion
Platelet aggregation in type 1diabetes withouth microvascular disease during continuous subcutaneous insulin infusion // Hormone and metabolic research, 28 (1996), 2; 95-100 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 26277 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Platelet aggregation in type 1diabetes withouth
microvascular disease during continuous
subcutaneous insulin infusion
Autori
Turk, Zdenka ; Flego, Iris ; Kerum, Gorazd
Izvornik
Hormone and metabolic research (0018-5043) 28
(1996), 2;
95-100
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Diabetes ; Platelet aggregation ; Thromboxane synthesis ; Insulin infusion
Sažetak
The effect of metabolic control on platelet activities was studied in eleven insulin-dependent diabetic patients during six months of continuous insulin infusion (CSII) treatment in comparison to three months of conventional therapy. Diabetic patients chosen for the study were free of microvascular disease. Glycemia control was improved during CSII treatment and a significant hemoglobin A(1c) reduction from 8.26 +/- 1.78 to 6.16 +/- 0.46%, p < 0.001, was achieved. The accompanying improvement in platelet aggregation in response to two agonists was only observed with the achievement of glycemia control (ADP: 20.84 +/- 4.61 vs 14.84 +/- 3.03%, p < 0.001 ; arachidonic acid: 22.04 +/- 4.26 vs 16.0 +/- 3.15%, p < 0.01). The synthesis of proaggregatory thromboxane B-2, as a response to arachidonate, was lower during the CSII period (TxB(2): 415 +/- 51 vs 382 +/- 36 mu g/l . 10(6) platelets), but with no statistical significance. Inspite of the fact that in all patients, lipoprotein concentrations were of normal values both before and after intensified therapy (HDL-c: 1.48 +/- 0.5 vs 1.52 +/- 0.4 mmol/l, NS ; LDL-c: 3.2 +/- 1.3 vs 2.7 +/- 1.0 mmol/l, NS), a significant correlation was observed between the atherogenic lipoprotein fraction and aggregation parameters. Thus, in all patients, LDL-cholesterol before and during CSII showed a significant correlation with platelet sensitivity to ADP (r = 0.61, p < 0.002), whereas at the same time its correlation with the corresponding values of HDL- cholesterol (r = -0.52, p < 0.01) was negative. Our results suggested that intensive insulin treatment reduced platelet aggregation in patients without microvascular disease when strict glycemia control was maintained and indicated that changes in platelet aggregation could directly result from changes in plasma glucose concentrations.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
045003
Ustanove:
Klinika za dijabetes, endokrinologiju i bolesti metabolizma Vuk Vrhovac
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
Uključenost u ostale bibliografske baze podataka::
- Index Medicus
- Excerpta Medica
- CABS
- PubMed